Copyright © 2016 A Real Headache: Anticoagulation and A Subdural Hematoma COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.

Slides:



Advertisements
Similar presentations
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Advertisements

Clearing the Air COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Concomitant Antiplatelet and OAC Tx: Real-World Practice In the US, ~800,000 AF patients are on concomitant OAC and antiplatelet tx 1 Patients on chronic.
What Does Aortic Stenosis Have to Do With Heme Positive Stool? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Hyperacute Stroke Treatment: Inclusion and Exclusion Criteria
Bob’s Bet COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Twisted After Surgery: What Caused Torsades? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Green Urine!? COPYRIGHT © 2013, ALL RIGHTS RESERVED From the Publishers of.
CLINICAL CASES.
A Pain in the Back COPYRIGHT © 2013, ALL RIGHTS RESERVED From the Publishers of.
Is that Hemoglobin High Enough? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.
Clean Coronaries But a Broken Heart COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
For the Long Haul: Improving Longevity After MI COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Balancing the Medication Portfolio 5 Years after a Heart Attack COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Anticoagulation? Antiplatelet? What’s the Score? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Too Close for Comfort? For How Long Must I Stop This Anticoagulant For an Epidural? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Is this 23 year old having a myocardial infarction? COPYRIGHT © 2013, ALL RIGHTS RESERVED From the Publishers of.
Atrial Fibrillation: How Controlled is Well Controlled? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Surgery with a Prosthetic Valve- What about the Warfarin? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Blindness After Surgery- Can You See the Answer? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Spinal or General Anesthesia? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Perioperative Risk Assessment - Can You Get It Right?
Care of the Anti-coagulated Trauma Patient Julie Mayglothling, MD, FACEP Emergencies in Medicine March 8 th, 2012.
  Warfarin Dabigatran Rivaroxaban Apixaban Edoxaban Target
April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 2: UFH & LMWH.
Shoot From the Hip? Surgery With Aortic Stenosis COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Hyperglycemia-Am I A Control Freak? COPYRIGHT © 2013, ALL RIGHTS RESERVED From the Publishers of.
Emergency anticoagulant reversal B Vigué, DAR, CHU Bicêtre.
Proceed to Surgery? Are You Kidding Me? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
The Asymptomatic Carotid Bruit: Not Such a Pain in the Neck After All? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Dressed to Kill? Can Neckties Spread Infection? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
Praxbind® - Idarucizumab
Excluding the Diagnosis of Pulmonary Embolism: Is There a Magic Ball? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
A Case of Hypertension: Overcoming Resistance Requires Change COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Anticoagulants and reversal
VTE: Is There Cancer? From the Publishers of
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
CHADS, SHMADS: What’s All This About Anticoagulation? COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
Stroke Protocol Time Lost Is Brain Lost!. Objective: Improve patient care & outcomes Offer a standard of care Increase efficiency Meet accreditation recommendations.
Homans Sign: A Sign of What? COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
Anticoagulation in Atrial Fibrillation Dalia Hawwass PGY2 June 2015.
Bleeding complications and management in patients treated with NOACs
Serving Up Advice: A Waiter With Hematuria COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseClinical Perspective by Michael D. Ezekowitz, Rangadham.
Fact or Fiction: O2 for Myocardial Infarction?
Risk With Atrial Fibrillation: A Guy Thing?
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated with Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Postoperative Calf Venous Thrombosis: Location, Location, Location
In the Hot Seat: What Is This Rash After Low-Molecular-Weight Heparin?
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Difficult situations in anticoagulation after stroke
You can never be too Thin…. An Update on NOACs
A Comparison of RE-LY and ROCKET AF Trial Designs and Outcomes
Guide on how to manage atrial fibrillation in the office
Anticoagulation in Atrial Fibrillation
Judith Misas, Pharm.D. Candidate PGY1 Residency Interview
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
RE-CIRCUIT Trial design: Patients with atrial fibrillation undergoing catheter ablation were randomized to uninterrupted dabigatran 150 mg twice daily.
Oral Anticoagulants and Reversal Agents
Novel oral anticoagulants in comparison with warfarin
Click here for title Click here for subtitle
“Reversing Direct Oral Anticoagulants”
A Stumper: How Much Spent for How Much Prevention?
Evidence Supporting Idarucizumab for the Reversal of Dabigatran
Oral Anticoagulant Reversal Agents
What Does Aortic Stenosis Have to Do With Heme Positive Stool?
Which NOAC and When for Stroke Prevention in AF?
A Real Headache: Anticoagulation and a Subdural Hematoma
Presentation transcript:

Copyright © 2016 A Real Headache: Anticoagulation and A Subdural Hematoma COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of

Terms of Use The Consult Guys ® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the Consult Guys ® slide sets constitutes copyright infringement. Copyright © 2016

Guys: Need your help. I am in our Emergency Department and have just seen a 70-year-old woman who fell. She has a history of chronic atrial fibrillation, hypertension, and diabetes. She takes chronic anticoagulation. Meds: rivaroxaban 20 mg, daily, atenolol 25 mg, metformin 500mg, BID PMHx: HBP, DM II, Non Valvular Afib SHx: non-smoker, no ETOH, married, lives with family Exam: BP 120/78, A Fib Ventricular Rate: 80 and afebrile Lungs clear Heart irregular rhythm, S1S2 normal, no murmurs No focal neurologic signs, alert and oriented Labs: N 134, K 3.4, Cr 1.2, CrCl 62cc/min, Hgb 12.8, Hct 38, WBC 8K, Plts 240K, UA neg, PT/ INR 11 sec/0.8, aPTT 32 sec ECG: atrial fibrillation Chest x-ray: unremarkable Guys: Need your help. I am in our Emergency Department and have just seen a 70-year-old woman who fell. She has a history of chronic atrial fibrillation, hypertension, and diabetes. She takes chronic anticoagulation. Meds: rivaroxaban 20 mg, daily, atenolol 25 mg, metformin 500mg, BID PMHx: HBP, DM II, Non Valvular Afib SHx: non-smoker, no ETOH, married, lives with family Exam: BP 120/78, A Fib Ventricular Rate: 80 and afebrile Lungs clear Heart irregular rhythm, S1S2 normal, no murmurs No focal neurologic signs, alert and oriented Labs: N 134, K 3.4, Cr 1.2, CrCl 62cc/min, Hgb 12.8, Hct 38, WBC 8K, Plts 240K, UA neg, PT/ INR 11 sec/0.8, aPTT 32 sec ECG: atrial fibrillation Chest x-ray: unremarkable Copyright © 2016

Do We Reverse the Anticoagulation? Last dose of rivaroxaban was 6 PM the evening prior to having CT scan of head CT performed at 11 AM 17 hours since last rivaroxaban dose Half-Life rivaroxaban 8 hours Clearance rivaroxaban: 30% renal, 60% liver Half-LifeFraction Remaining% Remaining 11/250% 21/425%*** 31/812.5% 41/166.25% 51/ %

Copyright © 2016 Rivaroxaban RESCUE: Four Factor vs Three Factor PCC (prothrombin complex concentrate) AgentReduction PT (sec) Beriplex (50 IU/kg) Four Factor (II,VII,IX,X) 2.5 sec – 3.5 sec Profilnine (50 IU/kg) Three Factor(II,IX,X) 0.6 – 1.0 sec Rivaroxaban 20mg, BID x 4 days 30 minute following infusion: effect noted on reducing the prothrombin time *Levi M et al. Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost Sep;12(9): doi: /jth Epub 2014 Jul 24.

Correction: The Consult Guys—A Real Headache: Anticoagulation and a Subdural Hematoma In a recent Consult Guys video (1), the computed tomography image of the head originally included in the video at 1:56 showed a shift of midline structures in association with a hematoma. This has been replaced with a correct image, demonstrating a hematoma with no shift of midline structures. Reference 1.Merli GJ, Weitz HH. The Consult Guys—A Real Headache: Anticoagulation and a Subdural Hematoma [video]. Ann Intern Med. 2016;164. Accessed at &resultClick=3 on 18 May [PMID: ] doi: /W Reproduced with permission from Suyash Mohan, MD

Copyright © 2016 Case Her CHA2DS2-VASc Score is 4 with a 4.0% yearly risk of stroke. How do I manage her stroke risk and need for anticoagulation?

Patients received 5 g of intravenous idarucizumab, which was administered as two 50-ml bolus infusions, each containing 2.5 g of idarucizumab, no more than 15 minutes apart. The 5- g dose was calculated to reverse the total body load of dabigatran that was associated with the 99th percentile of the dabigatran levels measured in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. *Pollack C, et al. Idarucizumab for Dabigatran Reversal. N Engl J Med. 2015; 373:

*Siegal DM, et al. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. N Engl J Med. 2015; 373: mg, IV, Bolus (30mg/min) 400 mg, IV, Bolus (30mg/min) the Infusion 4mg/min for 120min (480mg total )

Chart Review 2869 patient warfarin related intracranial hemorrhage 36% were subdural hematomas Optimal Time for Resumption warfarin 10 to 30 weeks *Majeed A 1, Kim YK, Roberts RS, Holmström M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke Dec;41(12): doi: /STROKEAHA Epub 2010 Oct 28.

*Nielsen PB et al.Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding Circulation. 2015; 132: Patients Danish Registry NV-Afib with ICH Rate of Ischemic Stroke: Restart OAC 13.6 Rate of Ischemic Stroke: ASA 25.7 Rate of Ischemic Stroke: No OAC 27.3

Copyright © 2016 Summary Patient with atrial fibrillation and traumatic subdural hematoma with minimal symptoms. When to restart anticoagulation? 7-14 days (risk/benefit taken into consideration)

Copyright © 2016 COPYRIGHT © 2016, ALL RIGHTS RESERVED Produced by and